Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00957476 · ClinicalTrials.gov registry record · NA
Omega-3 Supplementation Decreases Inflammation and Fetal Obesity in Pregnancy
A NA study, sponsored by MetroHealth Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 72
- Enrollment target
NCT00957476: Completed NA study, sponsored by MetroHealth Medical Center.
NCT00957476 is a NA study that has completed, run by MetroHealth Medical Center. The registered enrollment target is 72 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00957476, a NA study, has completed, sponsored by MetroHealth Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
Study Summary
Randomized, double-blind placebo controlled trial of fish oil to decrease inflammation in pregnancy.
Primary Outcome
cytokine concentration in plasma, placenta and white adipose tissue
Interventions
- DIETARY_SUPPLEMENT Omega-3 Fish Oil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2009-09 |
| Est. Completion | 2013-06 |
| Phase | NA |
What the finished NCT00957476 record still lists
NCT00957476 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Omega-3 Fish Oil is the first listed.
NCT00957476 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00957476 about?
NCT00957476 is a clinical study titled "Omega-3 Supplementation Decreases Inflammation and Fetal Obesity in Pregnancy". Randomized, double-blind placebo controlled trial of fish oil to decrease inflammation in pregnancy.
What is the current status of trial NCT00957476?
This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2009-09. Estimated completion is 2013-06.
What interventions are being tested in trial NCT00957476?
The interventions under investigation include: Omega-3 Fish Oil (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00957476?
This trial is sponsored by MetroHealth Medical Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00957476's enrollment target sits among peer trials
72 1089th of 2000 higher than 899 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia